Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease

BACKGROUND: Hypoglycemia is common in patients with end-stage renal disease (ESRD). We identified the incidence and timing of hypoglycemia and its risk factors in hospitalized patients with ESRD after the treatment of hyperkalemia with insulin. METHODS: We conducted a retrospective study of all hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Apel, Jill, Reutrakul, Sirimon, Baldwin, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377748/
https://www.ncbi.nlm.nih.gov/pubmed/25852884
http://dx.doi.org/10.1093/ckj/sfu026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377748/
https://www.ncbi.nlm.nih.gov/pubmed/25852884
http://dx.doi.org/10.1093/ckj/sfu026

Ejemplares similares